ME01367B - Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto - Google Patents

Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto

Info

Publication number
ME01367B
ME01367B MEP-2008-672A MEP67208A ME01367B ME 01367 B ME01367 B ME 01367B ME P67208 A MEP67208 A ME P67208A ME 01367 B ME01367 B ME 01367B
Authority
ME
Montenegro
Prior art keywords
preparation
crystalline form
novel
pharmaceutical compositions
compositions containing
Prior art date
Application number
MEP-2008-672A
Other languages
English (en)
French (fr)
Inventor
Gerard Coquerel
Bruno Pfeiffer
Yves Michel Ginot
Stephane Beilles
Original Assignee
Les Laboratoires Serviers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01367(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Serviers filed Critical Les Laboratoires Serviers
Publication of ME01367B publication Critical patent/ME01367B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Pronalazak se odnosi na kristalni oblik jedinjenja sa formulom (I) koji se karakteriše dijagramom praha (rendgenske difrakcije). Pronalazak je primenljiv za dobijanje lekova u medicini. Pronalazak se odnosi na kristalni oblik jedinjenja sa formulom (I) koji se karakteriše dijagramom praha (rendgenske difrakcije). Pronalazak je primenljiv za dobijanje lekova u medicini.
MEP-2008-672A 2000-07-06 2001-07-06 Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto ME01367B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008791A FR2811318B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002169 WO2001083439A2 (fr) 2000-07-06 2001-07-06 NOUVELLE FORME CRISTALLINE η DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (1)

Publication Number Publication Date
ME01367B true ME01367B (me) 2013-12-20

Family

ID=8852170

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-672A ME01367B (me) 2000-07-06 2001-07-06 Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto

Country Status (36)

Country Link
US (2) US20030158121A1 (me)
EP (1) EP1296948B1 (me)
JP (2) JP3592296B2 (me)
KR (1) KR100513572B1 (me)
CN (1) CN1328258C (me)
AP (1) AP1452A (me)
AR (1) AR029570A1 (me)
AT (1) ATE249435T1 (me)
AU (2) AU2001276420B2 (me)
BG (1) BG66239B1 (me)
BR (1) BR0112211A (me)
CA (1) CA2415447C (me)
CZ (1) CZ302022B6 (me)
DE (1) DE60100761T2 (me)
DK (1) DK1296948T3 (me)
EA (1) EA004275B1 (me)
EE (1) EE05286B1 (me)
ES (1) ES2206423T3 (me)
FR (1) FR2811318B1 (me)
GE (1) GEP20043362B (me)
HK (1) HK1058199A1 (me)
HR (1) HRP20030078B1 (me)
HU (1) HU228115B1 (me)
ME (1) ME01367B (me)
MX (1) MXPA02012904A (me)
NO (1) NO323445B1 (me)
NZ (1) NZ523311A (me)
OA (1) OA12306A (me)
PL (1) PL348491A1 (me)
PT (1) PT1296948E (me)
RS (1) RS51621B (me)
SI (1) SI1296948T1 (me)
SK (1) SK287452B6 (me)
UA (1) UA57187C2 (me)
WO (1) WO2001083439A2 (me)
ZA (1) ZA200300025B (me)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
ATE540924T1 (de) 2003-06-24 2012-01-15 Servier Lab Neue kristalline formen von perindopril erbumine
WO2005019173A1 (en) * 2003-08-21 2005-03-03 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
DE60330603D1 (de) 2003-10-21 2010-01-28 Servier Lab Verfahren zur herstellung kristallinem perindopril erbumin
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
ES2603856T3 (es) * 2004-03-29 2017-03-01 Les Laboratoires Servier Procedimiento para preparar una composición farmacéutica sólida
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
US20090099370A1 (en) * 2005-08-12 2009-04-16 Sandoz Ag Crystalline Form of Perindopril Erbumine
CA2618561C (en) * 2005-08-12 2014-04-29 Lek Pharmaceuticals D.D. A process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
DK2318365T3 (en) * 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
KR200453510Y1 (ko) * 2009-02-09 2011-05-11 윤유원 튀김유 정제기
KR101041878B1 (ko) * 2009-03-26 2011-06-15 신준호 튀김장치용 찌꺼기 제거장치
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
HU228115B1 (hu) 2012-11-28
SK1502003A3 (en) 2003-06-03
HRP20030078A2 (en) 2003-04-30
EP1296948B1 (fr) 2003-09-10
EA004275B1 (ru) 2004-02-26
GEP20043362B (en) 2004-06-10
HUP0102814A2 (hu) 2002-02-28
CA2415447A1 (fr) 2001-11-08
PL348491A1 (en) 2002-01-14
JP5016184B2 (ja) 2012-09-05
AP1452A (en) 2005-07-11
NO20030051L (no) 2003-01-06
CA2415447C (fr) 2008-12-09
SI1296948T1 (en) 2003-12-31
WO2001083439A2 (fr) 2001-11-08
NO20030051D0 (no) 2003-01-06
CN1328258C (zh) 2007-07-25
KR20030024774A (ko) 2003-03-26
BG107534A (bg) 2003-12-31
BR0112211A (pt) 2003-05-06
JP2005002120A (ja) 2005-01-06
CZ2003358A3 (cs) 2003-05-14
JP2003531890A (ja) 2003-10-28
DE60100761D1 (de) 2003-10-16
AR029570A1 (es) 2003-07-02
ES2206423T3 (es) 2004-05-16
UA57187C2 (uk) 2003-06-16
DE60100761T2 (de) 2004-07-15
NO323445B1 (no) 2007-05-07
MXPA02012904A (es) 2003-09-22
YU100302A (sh) 2003-08-29
HU0102814D0 (en) 2001-09-28
HK1058199A1 (en) 2004-05-07
CZ302022B6 (cs) 2010-09-08
SK287452B6 (sk) 2010-10-07
US20040248817A1 (en) 2004-12-09
FR2811318B1 (fr) 2002-08-23
BG66239B1 (bg) 2012-08-31
DK1296948T3 (da) 2004-01-05
ATE249435T1 (de) 2003-09-15
HUP0102814A3 (en) 2003-12-29
PT1296948E (pt) 2003-12-31
ZA200300025B (en) 2004-02-10
EE05286B1 (et) 2010-04-15
AU2001276420B2 (en) 2006-11-16
CN1440386A (zh) 2003-09-03
AU7642001A (en) 2001-11-12
EP1296948A2 (fr) 2003-04-02
RS51621B (sr) 2011-08-31
US20030158121A1 (en) 2003-08-21
FR2811318A1 (fr) 2002-01-11
HRP20030078B1 (en) 2004-06-30
KR100513572B1 (ko) 2005-09-09
WO2001083439A3 (fr) 2002-02-07
OA12306A (en) 2003-12-23
NZ523311A (en) 2004-06-25
JP3592296B2 (ja) 2004-11-24
AP2002002709A0 (en) 2002-12-31
EA200300104A1 (ru) 2003-06-26
EE200300003A (et) 2004-08-16

Similar Documents

Publication Publication Date Title
ME01367B (me) Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto
HRP20060361A8 (en) Novel c-crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
GEP20043361B (en)  Crystalline Form of Perindopril Tert-Butylamine Salt,
ME00454B (me) Nova so perindoprila i farmaceutske kompozicije koje sadrže tu so
JO2793B1 (en) The new crystalline form 5 of agomelatine, its preparation process and the pharmaceutical ingredients it contains
HRP20040933B1 (hr) Postupak primjene antikolinergika putem inhalacije
JO3360B1 (ar) الشكل البلوري الجديد 3 للأغوميلاتين وعملية تحضيره والمكونات الصيدلانية التي تحتويه
ATE520406T1 (de) Kristalline form des ibandronat-natriums
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
MY143557A (en) Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it
MY151035A (en) ? crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
MXPA05014068A (es) Dicetopiperazinas sustituidas y su uso como antagonistas de oxitocina.
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
EA202090281A1 (ru) Фармацевтическое соединение, способ его получения и применения в качестве лекарственного средства
MY138209A (en) New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
FR2825092A1 (fr) Nouveau derives trycicliques de dihydro-quinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPS60188330A (ja) １，３−ジオキサン誘導体を含有する経口薬の製剤方法
TNSN05077A1 (en) New y crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
TNSN05078A1 (en) New beta crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
MY142738A (en) Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt